Jazz Pharmaceuticals (JAZZ) Short term Debt (2010 - 2026)
Jazz Pharmaceuticals' quarterly Short term Debt came in at $1.0 billion in Q1 2026, up 3224.19% year-on-year from $31.0 million in Q1 2025, and little changed quarter-over-quarter from $1.0 billion in Q4 2025.
Jazz Pharmaceuticals has reported Short term Debt for 17 years, with the latest figure at $1.0 billion in Q1 2026.
- For the quarter ending Q1 2026, Short term Debt rose 3224.19% year-over-year to $1.0 billion; the trailing twelve-month figure through Mar 2026 stood at $1.0 billion (up 3224.19% YoY), and the FY2025 full-year result was $1.0 billion, up 3222.26% from the prior year.
- Short term Debt for Q1 2026 stood at $1.0 billion, roughly flat from $1.0 billion in the prior quarter.
- The five-year high for Short term Debt was $1.0 billion in Q1 2026, with the low at $31.0 million in Q1 2022.
- Average Short term Debt over 5 years is $401.0 million, with a median of $31.0 million recorded in 2022.
- Year-over-year, Short term Debt slumped 94.88% in 2025 and jumped 3224.19% in 2026.
- Tracing JAZZ's Short term Debt over 5 years: stood at $31.0 million in 2022, then soared by 1851.46% to $605.0 million in 2023, then sank by 94.88% to $31.0 million in 2024, then jumped by 3222.26% to $1.0 billion in 2025, then increased by 0.06% to $1.0 billion in 2026.
- The last three Short term Debt figures came in at $1.0 billion (Q1 2026), $1.0 billion (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.03 Bn |
| Dec 31, 2025 | 1.03 Bn |
| Sep 30, 2025 | 1.03 Bn |
| Jun 30, 2025 | 1.03 Bn |
| Mar 31, 2025 | 31.00 Mn |
| Dec 31, 2024 | 31.00 Mn |
| Sep 30, 2024 | 31.00 Mn |
| Jun 30, 2024 | 605.80 Mn |
| Mar 31, 2024 | 605.38 Mn |
| Dec 31, 2023 | 604.95 Mn |
| Sep 30, 2023 | 604.51 Mn |
| Jun 30, 2023 | 31.00 Mn |
| Mar 31, 2023 | 31.00 Mn |
| Dec 31, 2022 | 31.00 Mn |
| Sep 30, 2022 | 31.00 Mn |
| Jun 30, 2022 | 31.00 Mn |
| Mar 31, 2022 | 31.00 Mn |
| Dec 31, 2021 | 31.00 Mn |
| Sep 30, 2021 | 31.00 Mn |
| Jun 30, 2021 | 248.59 Mn |
| Mar 31, 2021 | 248.61 Mn |
| Dec 31, 2020 | 246.32 Mn |
| Sep 30, 2020 | 244.00 Mn |
| Jun 30, 2020 | 33.39 Mn |
| Mar 31, 2020 | 33.39 Mn |
| Dec 31, 2019 | 33.39 Mn |
| Sep 30, 2019 | 33.39 Mn |
| Jun 30, 2019 | 33.39 Mn |
| Mar 31, 2019 | 33.39 Mn |
| Dec 31, 2018 | 33.39 Mn |
| Sep 30, 2018 | 33.39 Mn |
| Jun 30, 2018 | 33.39 Mn |
| Mar 31, 2018 | 45.12 Mn |
| Dec 31, 2017 | 40.61 Mn |
| Sep 30, 2017 | 36.09 Mn |
| Jun 30, 2017 | 36.09 Mn |
| Mar 31, 2017 | 136.09 Mn |
| Dec 31, 2016 | 36.09 Mn |
| Sep 30, 2016 | 36.09 Mn |
| Jun 30, 2016 | 37.50 Mn |
| Mar 31, 2016 | 37.59 Mn |
| Dec 31, 2015 | 37.59 Mn |
| Sep 30, 2015 | 117.59 Mn |
| Jun 30, 2015 | 28.48 Mn |
| Mar 31, 2015 | 9.39 Mn |
| Dec 31, 2014 | 9.43 Mn |
| Sep 30, 2014 | 9.44 Mn |
| Jun 30, 2014 | 9.47 Mn |
| Mar 31, 2014 | 9.51 Mn |
| Dec 31, 2013 | 5.57 Mn |
| Sep 30, 2013 | 5.57 Mn |
| Jun 30, 2013 | 5.57 Mn |
| Mar 31, 2013 | 32.66 Mn |
| Dec 31, 2012 | 29.69 Mn |
| Sep 30, 2012 | 26.72 Mn |
| Jun 30, 2012 | 23.75 Mn |
| Jun 30, 2011 | 4.00 Mn |
| Dec 31, 2010 | 7.35 Mn |